GH Research (GHRS) Revenue & Revenue Breakdown
GH Research Revenue Highlights
0
Latest Revenue (Q)
$80.00K
GH Research Revenue by Period
GH Research Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | - |
GH Research Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-03-31 | $80.00K | 100.00% |
2023-12-31 | - | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | - |
GH Research Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
RCUS | Arcus Biosciences | $117.00M | $48.00M |
RLAY | Relay Therapeutics | $25.55M | - |
HOWL | Werewolf Therapeutics | $19.94M | $1.14M |
IKNA | Ikena Oncology | $9.16M | - |
STOK | Stoke Therapeutics | $8.78M | $4.89M |
JANX | Janux Therapeutics | $8.08M | $8.90M |
MOLN | Molecular Partners | $7.04M | $2.74M |
MNOV | MediciNova | $1.00M | - |
ANEB | Anebulo Pharmaceuticals | - | - |
DSGN | Design Therapeutics | - | - |
RZLT | Rezolute | - | - |
CGEM | Cullinan Oncology | - | - |
GPCR | Structure Therapeutics | - | - |
GHRS | GH Research | - | $80.00K |
PHVS | Pharvaris | - | - |
CYT | Cyteir Therapeutics | - | - |
ANNX | Annexon | - | - |
ELYM | Eliem Therapeutics | - | - |
PMVP | PMV Pharmaceuticals | - | - |
MLYS | Mineralys Therapeutics | - | - |
GLUE | Monte Rosa Therapeutics | - | $4.70M |
PEPG | PepGen | - | - |
CSBR | Champions Oncology | - | - |